I. Paunović, “Coexistence of BRAFV600E mutation and EGFR overexpression is highly associated with adverse clinicopathological features of papillary thyroid carcinoma”, Arch Biol Sci, vol. 72, no. 1, pp. 37–44, Mar. 2020.